Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Health Policy

PND50 Estimation of the Effect of Dalfampridine Extended Release on Health Utility in Patients With Multiple Sclerosis Using Two Equations for Mapping the MSWS-12 to the EQ-5D

Value in Health

English

Pcv19 a Bayesian Multiple Treatment Comparison of Pulmonary Arterial Hypertension Drug Classes Based on the Risk of Mortality Reported in Clinical Trials

English

Analysis of Cardiovascular Disease Burden on the Insured Population of Units Directly Under Fujian Province

English

PND8 Cost Reductions Associated With the Use of Botulinum Toxin Type a for the Treatment of Urinary Incontinence in Patients With Neurogenic Detrusor Overactivity

English

Measuring the Impact of Secondary Progressive Multiple Sclerosis (Spms) in the Ascend Trial: Equating the Msis-29, MSWS-12, Abilhand-56 and Sf-36

English

PUK10 Cost-Effectiveness Analysis of Solifenacin Versus Oxybutynin Immediate-Release in the Treatment of Patients With Overactive Bladder in the United Kingdom

English

Regulatory and General Epidemiological Knowledge About Rare Diseases and Access to Treatment for Rare Diseases: Health Professionals’ View in Serbia

English

Analysis on the Annual Medical Burden of Basic Medical Insurance Participants

English

PCN149 Uncertainty Regarding NICE's End-Of-Life Small Patient Population Criteria

English

Factors Affecting Parents’ Knowledge and Practice About Childhood Immunization: Experience From Malaysia

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Health Policy

PND50 Estimation of the Effect of Dalfampridine Extended Release on Health Utility in Patients With Multiple Sclerosis Using Two Equations for Mapping the MSWS-12 to the EQ-5D

Pcv19 a Bayesian Multiple Treatment Comparison of Pulmonary Arterial Hypertension Drug Classes Based on the Risk of Mortality Reported in Clinical Trials

Analysis of Cardiovascular Disease Burden on the Insured Population of Units Directly Under Fujian Province

PND8 Cost Reductions Associated With the Use of Botulinum Toxin Type a for the Treatment of Urinary Incontinence in Patients With Neurogenic Detrusor Overactivity

Measuring the Impact of Secondary Progressive Multiple Sclerosis (Spms) in the Ascend Trial: Equating the Msis-29, MSWS-12, Abilhand-56 and Sf-36

PUK10 Cost-Effectiveness Analysis of Solifenacin Versus Oxybutynin Immediate-Release in the Treatment of Patients With Overactive Bladder in the United Kingdom

Regulatory and General Epidemiological Knowledge About Rare Diseases and Access to Treatment for Rare Diseases: Health Professionals’ View in Serbia

Analysis on the Annual Medical Burden of Basic Medical Insurance Participants

PCN149 Uncertainty Regarding NICE's End-Of-Life Small Patient Population Criteria

Factors Affecting Parents’ Knowledge and Practice About Childhood Immunization: Experience From Malaysia